Vertex Pharmaceuticals Incorporated shares owned by Compagnie Lombard, Odier SCA
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Compagnie Lombard, Odier SCA
from 13F filings
Historical chart of Compagnie Lombard, Odier SCA investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Compagnie Lombard, Odier SCA consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Compagnie Lombard, Odier SCA
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $5.7M | 13k | 453.36 |
| 2025-09-30 | $4.9M | 13k | 391.64 |
| 2025-06-30 | $5.6M | 13k | 445.20 |
| 2025-03-31 | $6.1M | 13k | 484.82 |
| 2024-12-31 | $3.9M | 9.6k | 402.70 |
| 2024-09-30 | $4.9M | 10k | 465.08 |
| 2024-06-30 | $3.4M | 7.2k | 468.72 |
| 2024-03-31 | $1.8M | 4.3k | 418.01 |
| 2023-12-31 | $529k | 1.3k | 406.89 |
| 2023-09-30 | $452k | 1.3k | 347.74 |
| 2023-06-30 | $669k | 1.9k | 351.91 |
| 2023-03-31 | $599k | 1.9k | 315.07 |
| 2022-12-31 | $1.6M | 5.5k | 288.72 |
| 2022-09-30 | $376k | 1.3k | 289.23 |
| 2022-06-30 | $460k | 1.6k | 282.21 |
| 2022-03-31 | $425k | 1.6k | 260.74 |
| 2021-12-31 | $358k | 1.6k | 219.63 |
| 2021-09-30 | $69k | 380 | 181.58 |
| 2021-06-30 | $76k | 380 | 200.00 |
| 2021-03-31 | $54k | 250 | 216.00 |
| 2020-06-30 | $94k | 325 | 289.23 |
| 2020-03-31 | $59k | 250 | 236.00 |
| 2018-12-31 | $50k | 300 | 166.67 |
| 2018-09-30 | $96k | 500 | 192.00 |
| 2018-06-30 | $85k | 500 | 170.00 |
| 2015-03-31 | $63k | 537 | 117.32 |
| 2014-09-30 | $204k | 1.8k | 112.21 |
| 2014-06-30 | $586k | 6.2k | 94.68 |
| 2014-03-31 | $261k | 3.7k | 70.87 |
| 2013-12-31 | $173k | 2.3k | 74.38 |
More positions owned by Compagnie Lombard, Odier SCA
View all positions for Compagnie Lombard, Odier SCA
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated